ArticleScientific reports2025
High alpha oscillations in portable prefrontal EEG indicate gender-sensitive biomarkers for emotional disorders.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From EEG signals to quantitative assessment: predicting depression severity using a novel deep learning framework.Scientific reports · 2026Article
- Immersive metaverse art as a psychological intervention for depression and anxiety: a narrative review and multilevel model integrating engagement, cultural identity, and neurocognitive mechanisms.Frontiers in psychology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a prevalent mental health condition associated with substantial emotional and functional impairment. While interest in neurophysiological markers is growing, gender-specific neural oscillatory patterns measured by portable electroencephalogram (EEG) devices remain underexplored. This study examined whether relative spectral power in the high alpha band (11-13 Hz), recorded by a three-channel prefrontal EEG device during eyes-closed resting state, is associated with emotional states and clinical diagnosis, with attention to gender differences. Forty participants from the MODMA dataset were included, comprising 18 patients with MDD (8 females, 10 males; mean age = 30.39 ± 10.91 years) and 22 healthy controls (8 females, 14 males; mean age = 30.86 ± 9.40 years). All participants completed EEG recordings using both a 128-channel laboratory system and a portable three-channel device (Fp1, Fpz, Fp2). Emotional status was assessed using the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Childhood Trauma Questionnaire-Short Form (CTQ-SF). Pearson correlations between relative spectral power and emotional scale scores were computed separately for males and females, with false discovery rate (FDR) correction applied to multiple comparisons. Spectral features from the portable EEG closely matched those of the lab system (r = 0.975). High alpha power was positively correlated with PHQ-9 and GAD-7 scores, with stronger and more extended correlations observed in females, sometimes reaching into the low beta range. After FDR correction, significant correlations were observed primarily at 11-14 Hz. At 11.9 Hz, PHQ-9 correlations were significant for both males (r = 0.40, p = 0.011) and females (r = 0.33, p = 0.037). High alpha power also distinguished MDD from controls (r = 0.32, p = 0.042), independent of age and education. Frontal high alpha activity measured by a portable EEG device is a promising neural marker of emotional dysregulation, with stronger and broader associations observed in females. These findings support gender-sensitive EEG-based screening approaches for mood disorders in community and clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.